Botulinum Toxin in the Management of Children with Cerebral Palsy

During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used medical intervention in children with cerebral palsy. In this review we consider the gaps in our knowledge in the use of BoNT-A and reasons why muscle morphology and function in children with cerebral palsy are...

Descripción completa

Detalles Bibliográficos
Autores principales: Multani, Iqbal, Manji, Jamil, Hastings-Ison, Tandy, Khot, Abhay, Graham, Kerr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682585/
https://www.ncbi.nlm.nih.gov/pubmed/31257556
http://dx.doi.org/10.1007/s40272-019-00344-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682585/
https://www.ncbi.nlm.nih.gov/pubmed/31257556
http://dx.doi.org/10.1007/s40272-019-00344-8

Ejemplares similares